Sarepta Therapeutics Inc (SRPT)
123.29
-2.71
(-2.15%)
USD |
NASDAQ |
Nov 01, 16:00
123.44
+0.15
(+0.12%)
After-Hours: 20:00
Sarepta Therapeutics 1 Year Total Returns (Daily): 61.12% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 61.12% |
October 31, 2024 | 87.19% |
October 30, 2024 | 18.70% |
October 29, 2024 | 21.89% |
October 28, 2024 | 21.93% |
October 25, 2024 | 22.29% |
October 24, 2024 | 16.40% |
October 23, 2024 | 16.59% |
October 22, 2024 | 15.49% |
October 21, 2024 | 14.49% |
October 18, 2024 | 11.65% |
October 17, 2024 | 4.72% |
October 16, 2024 | 7.12% |
October 15, 2024 | 4.89% |
October 14, 2024 | 5.43% |
October 11, 2024 | -0.20% |
October 10, 2024 | -0.37% |
October 09, 2024 | -4.41% |
October 08, 2024 | -3.40% |
October 07, 2024 | -4.96% |
October 04, 2024 | 2.20% |
October 03, 2024 | -1.40% |
October 02, 2024 | 3.31% |
October 01, 2024 | 0.92% |
September 30, 2024 | 3.03% |
Date | Value |
---|---|
September 27, 2024 | 0.88% |
September 26, 2024 | 4.55% |
September 25, 2024 | 8.61% |
September 24, 2024 | 4.64% |
September 23, 2024 | 4.05% |
September 20, 2024 | 7.83% |
September 19, 2024 | 6.71% |
September 18, 2024 | 5.90% |
September 17, 2024 | 6.16% |
September 16, 2024 | 5.01% |
September 13, 2024 | 4.77% |
September 12, 2024 | 4.58% |
September 11, 2024 | 8.44% |
September 10, 2024 | 5.86% |
September 09, 2024 | 6.49% |
September 06, 2024 | 4.93% |
September 05, 2024 | 10.95% |
September 04, 2024 | 10.02% |
September 03, 2024 | 10.28% |
August 30, 2024 | 13.41% |
August 29, 2024 | 14.36% |
August 28, 2024 | 17.12% |
August 27, 2024 | 18.19% |
August 26, 2024 | 17.94% |
August 23, 2024 | 22.80% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-60.62%
Minimum
Jul 19 2021
138.3%
Maximum
May 15 2023
7.26%
Average
3.83%
Median
1 Year Total Returns (Daily) Benchmarks
Regenxbio Inc | -38.06% |
Catalyst Pharmaceuticals Inc | 73.18% |
Vertex Pharmaceuticals Inc | 27.56% |
Entrada Therapeutics Inc | 13.55% |
Edgewise Therapeutics Inc | 427.1% |